Atypical manifestations of hepatitis A infection: A prospective, multicenter study in Korea

Journal of Medical Virology

Volumn 82, Issue 8, 2010, Pages 1318-1326

  Jung, Youn Mu ^a   Park, Sang Jong ^b   Kim, Jeong Sim ^a   Jang, Je Hyuck ^a   Lee, Sang Hyub ^a   Kim, Jin Wook ^a   Park, Young Min ^b   Hwang, Seong Gyu ^c   Rim, Kyu Sung ^c   Kang, Sook Kyoung ^d   Lee, Hyun Seok ^d   Yun, Hae Sun ^e   Jee, Young Mee ^e   Jeong, Sook Hyang ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

^c CHA University   (South Korea)

^d Seongnam Central Hospital   (South Korea)

^e Korea National Institute of Health   (South Korea)

Author keywords

Anti HAV antibody; Cholestasis; Hepatitis A virus; Kidney injury; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CREATININE; HEMOGLOBIN; HEPATITIS A ANTIBODY; IMMUNOGLOBULIN M;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE DURATION; FATALITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEPATITIS A; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; KIDNEY INJURY; KOREA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTHROMBIN TIME; SEROCONVERSION; THROMBOCYTE COUNT; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; COMPLICATION; HEPATITIS A VIRUS; HOSPITALIZATION; IMMUNOLOGY; INCIDENCE; KIDNEY DISEASES; LIVER FUNCTION TEST; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; RENAL REPLACEMENT THERAPY; TIME; VIROLOGY;

ADULT; CHOLESTASIS; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; KIDNEY DISEASES; KOREA; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

HEPATITIS A VIRUS;

EID: 77956605130     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21822     Document Type: Article

References (21)

1. Barzaga BN. 2000. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 18:S61-S64. (Pubitemid 30100469)
2. Bower WA, Nainan OV, Han X, Margolis HS. 2000. Duration of viremia in hepatitis A virus infection. J Infect Dis 182:12-17.
3. Cooksley WG. 2000. Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease. J Viral Hepat 7:29-30.
4. Coppola N, Genovese D, Pisaturo M, Taffon S, Argentini C, Pasquale G, Sagnelli C, Piccinino F, Rapicetta M, Sagnelli E. 2007. Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection. Clin Infect Dis 44:e73-e77.
5. Cuthbert JA. 2001. Hepatitis A: Old and new. Clin Microbiol Rev 14:38-58.
6. de Paula VS, Villar LM, Morais LM, Lewis-Ximenez LL, Niel C, Gaspar AM. 2004. Detection of hepatitis A virus RNA in serum during the window period of infection. J Clin Virol 29:254-259.
7. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, Chisari FV. 1996. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 93:4589-4594. (Pubitemid 26162806)
8. Keeffe EB. 1995. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90:201-205.
9. Kim HW, Yu MH, Lee JH, Chang JW, Yang WS, Kim SB, Lee SK, Park JS, Park SK. 2008. Experiences with acute kidney injury complicating non-fulminant hepatitis A. Nephrology (Carlton) 13:451-458.
10. Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, Lee DH, Lee W, Jeong SH. 2008. Hepatitis a in Korea: Epidemiological shift and call for vaccine strategy. Intervirology 51:70-74.
11. Locarnini S. 2000.Avirological perspective on the need for vaccination. J Viral Hepat 7:5-6.
12. Maier K, Gabriel P, Koscielniak E, Stierhof YD, Wiedmann KH, Flehmig B, Vallbracht A. 1988. Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol 62:3756-3763.
13. Martin A, Lemon SM. 2006. Hepatitis A virus: From discovery to vaccines. Hepatology 43:S164-S172.
14. Nainan OV, Xia G, Vaughan G, Margolis HS. 2006. Diagnosis of hepatitis a virus infection: A molecular approach. Clin Microbiol Rev 19:63-79.
15. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Scarano F, Marotta A, Scolastico C, Catuogno A, Salzillo A, Sagnelli C, Piccinino F, Filippini P. 2003. HAV replication in acute hepatitis with typical and atypical clinical course. J Med Virol 71:1-6.
16. Shroff GR, Badve SV, Joshi AG, Desai DC, Abraham P, Sirsat RA. 2004. Acute renal tubular injury with acute hepatitis A infection: Is it just a coincidence? Nephrology (Carlton) 9:44-46.
17. Song KS, Kim MJ, Jang CS, Jung HS, Lee HH, Kwon OS, Kim YS, Choi DJ, Kim JH, Ha SY. 2007. Clinical features of acute viral hepatitis A complicated with acute renal failure. Korean J Hepatol 13:166-173.
18. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, Hynan L, Lee WM, Fontana RJ. 2006. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 44:1589-1597.
19. Tong MJ, el-Farra NS, Grew MI. 1995. Clinical manifestations of hepatitis A: Recent experience in a community teaching hospital. J Infect Dis 171:S15-S18.
20. Trauner M, Fickert P, Stauber RE. 1999. Inflammation-induced cholestasis. J Gastroenterol Hepatol 14:946-959.
21. Zimmerman HJ, Lowry CF, Uyeyama K. 1947. Infectious hepatitis: Clinical and laboratory features of 295 cases. Am J Med Sci 213:395-409.